Catalyst Wire Dossier Catalyst Wire Dossier

Lantus (insulin glargine)

insulin glargine · Sanofi
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Lantus (insulin glargine), covering 2008-03-28 to 2017-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients [Phase 3]

See pricing